A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency … – 7thSpace Interactive (press release) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Continuing Education: ECG Clues to Identify the Site of Occlusion in Acute Myocardial Ischemia/Infar

Neuroprotective effects of enriched environment housing after transient global cerebral ischaemia are associated with the upregulation of insulin-like growth factor-1 signalling – Wadowska – 2015 -… »

A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency … – 7thSpace Interactive (press release)

May 30, 2015 by 2012pharmaceutical

A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency … – 7thSpace Interactive (press release)

Reporter: Aviva Lev-Ari, PhD, RN

A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome
– up-to-the-minute news and headlines.

Source: 7thspace.com

See on Scoop.it – Cardiovascular and vascular imaging

Posted in Atherogenic Processes & Pathology, Frontiers in Cardiology and Cardiovascular Disorders, Origins of Cardiovascular Disease | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 1,254 other subscribers
Recent Posts
- Press Release for Five Bilingual BioMed e-Series January 29, 2023
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
- Mission 4: Use of Systems Biology for Design of inhibitor of Galectins as Cancer Therapeutic – Strategy and Software December 13, 2022
- Science Has A Systemic Problem, Not an Innovation Problem December 12, 2022
- Chemistry Nobelist Carolyn Bertozzi’s years at UC Berkeley October 24, 2022
- Technion #1 in Europe in Field of AI for 2nd Straight Year October 20, 2022
- Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners October 11, 2022
- The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells October 11, 2022
- Cancer Policy Related News from Washington DC and New NCI Appointments October 4, 2022
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: